VERA logo

Vera Therapeutics (VERA)

Profile

Full Name

Vera Therapeutics, Inc.

Ticker Symbol

VERA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 14, 2021

Indexes

Not included

Website

http://veratx.com

Employees

112

Key Details

Price

$23.22(-1.07%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.75(-22.22% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$23.22
VERA price is $23.22

30-Day Relative Volume

0.91
VERA 30-day relative volume is 0.91

Price Performance

Price Most recent change

-1.07%
VERA price was down -1.07% on Apr 25, 2025

Price YTD change

-45.09%
VERA price is down -45.09% since January 1st

Price 1-year change

-39.98%
VERA price is down -39.98% year-on-year

Price 3-year change

+9.63%
VERA price is up +9.63% over the past 3 years

Price Range

Price All-time high

$51.61
VERA price is currently -55.01% below its historical high of $51.61

Price 3-year low

$5.20
VERA price is currently +346.54% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.48B
VERA market capitalization is $1.48 billion

Market cap 3-year change

+161.33%
VERA market capitalization is up +161.33% over the past 3 years

Market cap All-time high

$3.23B
VERA market capitalization is currently -54.16% below its historical high of $3.23 billion

Market cap sector rank

79.54%
VERA market capitalization is higher than 79.54% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+17.06%
VERA shares outstanding is up +17.06% year-on-year

Shares Outstanding 3-Year Change

+138.37%
VERA shares outstanding is up +138.37% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.19
VERA beta is 1.19

200-day SMA

$36.85
VERA price is currently -36.98% below its 200-day simple moving average

50-day SMA

$25.84
VERA price is currently -10.14% below its 50-day simple moving average

RSI

48.21
VERA 14-day relative strength index is 48.21

Volume

0.91
VERA 30-day relative volume is 0.91

ATR

$1.52
VERA average true range is $1.52

10-day Historical Volatility

45.11%
VERA 10-day historical volatility is 45.11%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
VERA annual revenue value is unknown

Revenue Analysts estimate

-
VERA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
VERA annual revenue 1-year change is unknown

Revenue Sector rank

-
VERA annual revenue is unknown

EPS

EPS

-$2.75
VERA annual earnings per share is -$2.75

EPS Analysts estimate

-$3.36
VERA annual earnings per share is currently -18.20% lower than the consensus analysts' forecast

EPS 1-year change

-22.22%
VERA annual earnings per share is down -22.22% year-on-year

EPS Sector rank

31.8%
VERA annual earnings per share is higher than 31.8% of companies in Healthcare sector

Profit

Gross profit

-
VERA annual gross profit value is unknown

Gross margin

-
VERA annual gross profit margin value is unknown

Operating profit

-$167.17M
VERA annual operating income is -$167.17 million

Operating margin

-
VERA annual operating profit margin value is unknown

Net income

-$152.15M
VERA annual net profit is -$152.15 million

Net margin

-
VERA annual net profit margin value is unknown

Expenses

Total expenses

$167.17M
VERA annual total expenses is $167.17 million

Operating expenses

$167.17M
VERA annual total operating expenses is $167.17 million

Cost of goods sold

-
VERA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$41.00M
VERA annual SGA is $41.00 million

Depreciation and amortization

$105.00K
VERA annual depreciation & amortization is $105.00 thousand

Interest expense

$7.63M
VERA annual interest expense is $7.63 million

Income tax

$1000.00
VERA annual income tax is $1000.00

EBIT & EBITDA

EBIT

-$167.17M
VERA annual earnings before interest & taxes is -$167.17 million

EBITDA

-$167.17M
VERA annual EBITDA is -$167.17 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$655.68M
VERA annual total assets is $655.68 million

Non current assets

$4.46M
VERA annual long term assets is $4.46 million

Current assets

$651.22M
VERA annual total current assets is $651.22 million

Cash and cash equivalents

$92.65M
VERA annual cash & cash equivalents is $92.65 million

Accounts receivable

-
VERA annual accounts receivable value is unknown

Inventory

-
VERA annual inventory value is unknown

Liabilities

Total liabilities

$78.53M
VERA annual total liabilities is $78.53 million

Long term liabilities

$53.16M
VERA annual total long term liabilities is $53.16 million

Current liabilities

$25.37M
VERA annual total current liabilities is $25.37 million

Accounts payable

$7.67M
VERA annual accounts payable is $7.67 million

Debt

Total debt

$54.64M
VERA annual total debt is $54.64 million

Total debt 1-year change

+1.73%
VERA annual total debt is up +1.73% year-on-year

Long term debt

$53.16M
VERA annual long term debt is $53.16 million

Short term debt

$1.48M
VERA annual short term debt is $1.48 million

Equity & Capital

Shareholders equity

$577.15M
VERA annual stockholders equity is $577.15 million

Book value

$577.15M
VERA annual book value is $577.15 million

Retained earnings

-$461.25M
VERA annual retained earnings is -$461.25 million

Working capital

$625.85M
VERA annual working capital is $625.85 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$134.68M
VERA annual cash flow from operations is -$134.68 million

Cash from operations 1-year change

-46.1%
VERA annual cash flow from operations is down -46.1% year-on-year

Cash from investing

-$425.03M
VERA annual cash flow from investing activities is -$425.03 million

Cash from investing 1-year change

-977.91%
VERA annual cash flow from investing activities is down -977.91% year-on-year

Cash from financing

$606.67M
VERA annual cash flow from financing activities is $606.67 million

Cash from financing 1-year change

+354.3%
VERA annual cash flow from financing activities is up +354.3% year-on-year

CAPEX

CAPEX

-
VERA annual capital expenditures value is unknown

CAPEX 1-year change

-
VERA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$135.65M
VERA annual free cash flow is -$135.65 million

Free cash flow 1-year change

-47.06%
VERA annual free cash flow is down -47.06% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
VERA annual gross profit margin value is unknown

Operating margin

-
VERA annual operating profit margin value is unknown

Net margin

-
VERA annual net profit margin value is unknown

ROA & ROE

ROA

-23.20%
VERA annual return on assets is -23.20%

ROE

-26.36%
VERA annual return on equity is -26.36%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
VERA price to earnings ratio value is unknown

PE ratio Sector rank

-
VERA price to earnings ratio is unknown

PB Ratio

PB ratio

2.56
VERA price to book ratio is 2.56

PB ratio Sector rank

67.81%
VERA price to book ratio is higher than 67.81% of companies in Healthcare sector

PS Ratio

PS ratio

-
VERA price to sales ratio value is unknown

PS ratio Sector rank

-
VERA price to sales ratio is unknown

Enterprise value

Enterprise value

$1.44B
VERA enterprise value is $1.44 billion

Enterprise value Sector rank

78.59%
VERA enterprise value is higher than 78.59% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-8.71
VERA EV/EBITDA is -8.71

EV/EBITDA Sector rank

13.29%
VERA EV/EBITDA is higher than 13.29% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

25.67
VERA annual current ratio is 25.67

Quick ratio

-
VERA annual quick ratio value is unknown

Leverage

Debt to equity

0.09
VERA annual debt to equity ratio is 0.09

Interest coverage ratio

-21.92
VERA annual interest coverage ratio is -21.92

Risk & Stability

Piotroski F-Score

-
VERA piotroski f-score value is unknown

Altman Z-Score

-
VERA altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 4, 25 JP Morgan
Overweight
Feb 27, 25 Guggenheim
Buy
Feb 4, 25 Wolfe Research
Outperform
Nov 21, 24 Wells Fargo
Overweight
Nov 8, 24 Wedbush
Neutral
Nov 5, 24 JP Morgan
Overweight
Oct 28, 24 Guggenheim
Buy
Oct 16, 24 Scotiabank
Sector Outperform
Oct 3, 24 Cantor Fitzgerald
Overweight
Oct 1, 24 Cantor Fitzgerald
Overweight

Institutional Ownership

Similar stocks

PACS logo
PACS (PACS)
EVO logo
Evotec SE (EVO)
NHC logo
National HealthCare (NHC)
MESO logo
Mesoblast Limited (MESO)
PHR logo
Phreesia (PHR)
ANIP logo
ANI Pharmaceuticals (ANIP)
IMCR logo
Immunocore Holdings (IMCR)
OMCL logo
Omnicell (OMCL)
Indivior (INDV)
  • What is the ticker symbol for Vera Therapeutics?
  • Does Vera Therapeutics pay dividends?
  • What sector is Vera Therapeutics in?
  • What industry is Vera Therapeutics in?
  • What country is Vera Therapeutics based in?
  • When did Vera Therapeutics go public?
  • Is Vera Therapeutics in the S&P 500?
  • Is Vera Therapeutics in the NASDAQ 100?
  • Is Vera Therapeutics in the Dow Jones?
  • When was Vera Therapeutics's last earnings report?
  • When does Vera Therapeutics report earnings?
  • Should I buy Vera Therapeutics stock now?

What is the ticker symbol for Vera Therapeutics?

The ticker symbol for Vera Therapeutics is NASDAQ:VERA

Does Vera Therapeutics pay dividends?

No, Vera Therapeutics does not pay dividends

What sector is Vera Therapeutics in?

Vera Therapeutics is in the Healthcare sector

What industry is Vera Therapeutics in?

Vera Therapeutics is in the Biotechnology industry

What country is Vera Therapeutics based in?

Vera Therapeutics is headquartered in United States

When did Vera Therapeutics go public?

Vera Therapeutics's initial public offering (IPO) was on May 14, 2021

Is Vera Therapeutics in the S&P 500?

No, Vera Therapeutics is not included in the S&P 500 index

Is Vera Therapeutics in the NASDAQ 100?

No, Vera Therapeutics is not included in the NASDAQ 100 index

Is Vera Therapeutics in the Dow Jones?

No, Vera Therapeutics is not included in the Dow Jones index

When was Vera Therapeutics's last earnings report?

Vera Therapeutics's most recent earnings report was on Nov 7, 2024

When does Vera Therapeutics report earnings?

The next expected earnings date for Vera Therapeutics is May 9, 2025

Should I buy Vera Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page